ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Senior Director - Security Posture & Exposure Management at Eli Lilly and Company - ApplyBlast

Senior Director - Security Posture & Exposure Management

Eli Lilly and Company

16 days ago

4.0 on Glassdoor

Remote

Full Time

Director

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Senior Director - Security Posture & Exposure Management at Lilly leads the enterprise vulnerability management program, owning the end-to-end process of identifying, prioritizing, and remediating security weaknesses. This hands-on technical leader directs teams across vulnerability management, application security, and offensive security to mature the function into a risk-based capability. The role involves setting technical strategy, establishing remediation SLAs, and reporting exposure progress to senior leadership.

Responsibilities

Lead enterprise vulnerability management program and security architecture
Establish risk-based prioritization standards and remediation SLAs
Oversee application security and offensive security programs

Skills

About Eli Lilly and Company

lilly.com

Headquarters

Indianapolis, Indiana, United States

Company Size

10001+ employees

Founded

1876

View Profile

Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.